AstraZeneca PLC (BCBA:AZN)
Argentina flag Argentina · Delayed Price · Currency is ARS
63,000
-2,875 (-4.36%)
At close: Oct 9, 2025
-4.36%
Market Cap376.34T
Revenue (ttm)67.33T
Net Income (ttm)9.89T
Shares Outn/a
EPS (ttm)6,326.07
PE Ratio38.07
Forward PE17.51
Dividend795.69 (1.19%)
Ex-Dividend DateAug 8, 2025
Volume3,886
Average Volume1,083
Open66,800
Previous Close65,875
Day's Range63,000 - 67,100
52-Week Range34,800 - 67,775
Betan/a
RSI56.41
Earnings DateNov 6, 2025

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, B... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 94,300
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol AZN
Full Company Profile

Financial Performance

In 2024, AstraZeneca's revenue was $54.07 billion, an increase of 18.03% compared to the previous year's $45.81 billion. Earnings were $7.04 billion, an increase of 18.14%.

Financial numbers in USD Financial Statements

News

There is no news available yet.